We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Merck To High Court: FDA Rejected Warning About Drug’s Fracture Risk

(September 17, 2018, 1:59 PM EDT) -- WASHINGTON, D.C. — Merck Sharp & Dohme Corp. on Sept. 13 filed its opening brief asking the U.S. Supreme Court to find that the Food and Drug Administration considered and rejected...
To view the full article, register now.